The main finding of this study was that patients with at least one polyp that harboured a KRAS mutation were at higher risk of developing advanced polyps, specifically, advanced adenomas, compared to patients with polyps that harboured BRAF mutations or no mutation. Here, KRAS is linked to adenoma.